COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES

被引：0
|
作者：
Jiang, M. [1 ]
Li, P. [1 ]
Zheng, X. [2 ]
Deng, J. [3 ]
Zhao, M. [1 ]
Fang, Y. [1 ]
机构：
[1] Xi An Jiao Tong Univ, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
[3] Shaanxi Prov Peoples Hosp, Xian, Shaanxi, Peoples R China
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.490
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV54
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China
    Jiang, Minghuan
    Li, Pengchao
    You, Joyce Hoi-sze
    Zheng, Xinglong
    Deng, Jizhao
    Zhao, Mingyue
    Feng, Liuxin
    Fang, Yu
    PLOS ONE, 2019, 14 (12):
  • [2] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380
  • [3] Cost-Effectiveness of Atorvastatin in the Primary Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes in Canada
    Khoury, Hanane
    Wagner, Monika
    Merikle, Elizabeth
    Johnson, Scott J.
    Roberts, Craig
    CANADIAN JOURNAL OF DIABETES, 2009, 33 (04) : 363 - 374
  • [4] Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
    Petersohn, Svenja
    Pouwels, Xavier
    Ramaekers, Bram
    ten Cate-Hoek, Arina
    Joore, Manuela
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (13) : 1354 - 1365
  • [5] Aspirin for primary prevention of cardiovascular events in diabetes
    Colwell, JA
    DIABETES CARE, 2003, 26 (12) : 3349 - 3350
  • [6] COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION
    Earnshaw, S.
    Pignone, M.
    Fendrick, A. M.
    Scheiman, J. M.
    McDade, C.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A166
  • [7] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Li, Te
    Wan, Xu
    Ma, Jin
    Wu, Bin
    ADVANCES IN THERAPY, 2018, 35 (12) : 2214 - 2223
  • [8] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Te Li
    Xu Wan
    Jin Ma
    Bin Wu
    Advances in Therapy, 2018, 35 : 2214 - 2223
  • [9] LONG-TERM COST-EFFECTIVENESS OF ADHERENCE TO ASPIRIN FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS
    Djatche, L.
    Varga, S.
    Liebertal, R.
    VALUE IN HEALTH, 2017, 20 (05) : A9 - A9
  • [10] Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Greving, Jacoba P.
    Buskens, Erik
    Koffijberg, Hendrik
    Algra, Ale
    CIRCULATION, 2008, 117 (22) : 2875 - 2883
12345